ALB and diabetic kidney disease: Exendin 4, administered for 8 weeks to C57BL/6J mice fed a high-fat diet and that were injected with streptozotocin, reduced urinary albumin and attenuated the progress of diabetic nephropathy via activation of renal AMP-activated protein kinase [38].